← Back
$VRNA All transactions

Verona Pharma plc

▼ SELL 10b5-1 Plan

$ Value

$1.5M

Shares

160,000

Price

$9

Filed

May 22

Insider

Name

Sinha Vikas

Title

CIK

0001337845

Roles

Director

Transaction Details

Transaction Date

2025-05-20

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

74,440

Footnotes

Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer. | The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 6, 2024. | The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were sold in multiple transactions at per share prices ranging from $9.375 to $9.4263, inclusive (or $75.00 to $75.41 per ADS, inclusive). The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3. | Consists of 74,440 Ordinary Shares represented by 9,305 ADSs. | The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer. | The option is fully vested.

Filing Info

Accession No.

0001104659-25-051986

Form Type

4

Issuer CIK

0001657312

Sinha Vikas's History

Date Ticker Type Value
2026-04-16 SRRK $516K
2025-10-07 VRNA D
2025-10-07 VRNA M
2025-10-07 VRNA D
2025-10-07 VRNA M
2025-10-07 VRNA D
2025-10-07 VRNA D
2025-10-07 VRNA D
2025-10-07 VRNA D
2025-08-01 VRNA M $0

Other Insiders at VRNA (90d)

No other insider activity at this issuer in the last 90 days.